KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Inventory (2017 - 2025)

Ionis Pharmaceuticals (IONS) has 9 years of Inventory data on record, last reported at $10.5 million in Q3 2025.

  • For Q3 2025, Inventory fell 63.2% year-over-year to $10.5 million; the TTM value through Sep 2025 reached $10.5 million, down 63.2%, while the annual FY2024 figure was $12.5 million, 68.15% up from the prior year.
  • Inventory reached $10.5 million in Q3 2025 per IONS's latest filing, up from $8.5 million in the prior quarter.
  • Across five years, Inventory topped out at $30.3 million in Q1 2024 and bottomed at $7.4 million in Q4 2023.
  • Average Inventory over 5 years is $20.6 million, with a median of $22.2 million recorded in 2023.
  • Peak YoY movement for Inventory: skyrocketed 68.15% in 2024, then crashed 70.47% in 2025.
  • A 5-year view of Inventory shows it stood at $24.8 million in 2021, then fell by 11.18% to $22.0 million in 2022, then plummeted by 66.23% to $7.4 million in 2023, then surged by 68.15% to $12.5 million in 2024, then dropped by 16.32% to $10.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory were $10.5 million in Q3 2025, $8.5 million in Q2 2025, and $11.5 million in Q1 2025.